Search Results 31-40 of 4424 for Diffuse

  1. A Study to Evaluate KD025 in Subjects with Diffuse Cutaneous Systemic Sclerosis - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of KD025 in patients with diffuse cutaneous systemic sclerosis. Upon eligibility ...

  2. Scleroderma - Symptoms and causes - Mayo Clinic

    Scleroderma also may cause problems in the blood vessels, internal organs and digestive tract. Scleroderma is often categorized as limited or diffuse, which ...

  3. Astrocytoma - Symptoms and causes - Mayo Clinic

    Diffuse astrocytomas spread into nearby brain tissue. Circumscribed defines the growth pattern and the category of the tumor, but not the grade. Pilocytic and ...

  4. Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL) - Mayo Clinic

    Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL) · Overview · Participation eligibility · Participating Mayo ...

  5. ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness of ONC201 administered following radiotherapy in participants with H3 K27M-mutant diffuse glioma.

  6. Quantitative Assessment of Skin and Liver of Patients with Diffuse Systemic Sclerosis Using Shear-Wave Ultrasound Elastography - Mayo Clinic

    Quantitative Assessment of Skin and Liver of Patients with Diffuse Systemic Sclerosis Using Shear-Wave Ultrasound Elastography · More about research at Mayo ...

  7. Doctors and departments - Mayo Clinic

    Research. Mayo Clinic doctors and scientists are working together to find new ways to diagnose and treat brain tumors, including diffuse midline glioma. Brain ...

  8. Fatty liver disease (MASLD) - Symptoms and causes - Mayo Clinic

    MASLD ranges in severity from hepatic steatosis — sometimes called diffuse hepatic steatosis, or formerly fatty liver infiltration or simply fatty liver ...

  9. Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139) - Mayo Clinic

    Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem ...

  10. Doctors and departments - Mayo Clinic

    Diffuse midline glioma (DMG). Research. Mayo Clinic doctors and scientists are working together to find new ways to diagnose and treat brain tumors, including ...